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Objectives: Bacterial urinary tract infections are a common diagnosis in small animal practice and anti-
biotics are often administered empirically. The aim of this study was to investigate the aetiology and 
antibiotic resistance of uropathogens in dogs and cats in the UK.
Materials and MethOds: Retrospective study of uroculture and antibiotic susceptibility testing 
results (n=808) by disk diffusion processed at a veterinary pathology laboratory between 2011 and 
2012.
results: Significant bacteriuria was detected in 18.4% of samples from dogs and 10.0% from cats, 
most of which (>90%) yielded a single organism. Escherichia coli was the most prevalent bacterial 
species (54.7% and 55.6% of feline and canine isolates, respectively) followed by Proteus mirabilis 
in dog samples (22.7%) and Enterococcus spp. in cat samples (23.2%). Approximately a third of E. coli 
isolates were resistant to ampicillin but resistance was much lower among Enterococcus spp. and 
P. mirabilis. Resistance to amoxicillin-clavulanic acid also seemed to be emerging, particularly in 
E. coli (almost 20% resistant). In contrast, resistance to trimethoprim-sulfamethoxazole for uropatho-
gens remained <13% except for P. mirabilis (19.4%). Overall, fluoroquinolones showed the best in vitro 
activity (resistance mostly below 10% for enrofloxacin and marbofloxacin).
clinical significance: Our results provide evidence of the emergence of resistance to antibiotics com-
monly used to treat bacterial urinary tract infections. Continued monitoring of the patterns of antibi-
otic resistance in uropathogens is needed to assess the adequacy of recommendations on the empiric 
therapy of these infections.
INTRODUCTION
Bacterial urinary tract infections (UTIs) are diagnosed in approx-
imately 14% of dogs during their lifetime (Ling 1984). UTIs are 
more common in cats aged 10 or above, those with concurrent 
diseases (e.g. diabetes mellitus, chronic renal failure) and those 
that have undergone urinary catheterisation or perineal urethros-
tomy (Lulich et al. 1992, Litster et al. 2007). UTIs can cause a 
spectrum of disease from asymptomatic to life threatening. The 
clinical signs known to be compatible with UTI include dysuria, 
stranguria, pollakiuria and hematuria, but such signs are not 
pathognomonic of infection. A diagnosis of UTI can be aided 
by the detection of significant bacteriuria in quantitative cultures 
of urine specimens (Weese et al. 2011, Olin & Bartges 2015). 
In the same manner, resolution of clinical signs is not a sign of 
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FIG 1. Geographic distribution of veterinary practices by number of (A) feline and (B) canine samples with significant bacteriuria (cut-off of ≥105 
colony-forming units (CFU)/mL and growth of up to two possible uropathogens). ★Location of NationWide Laboratories
UTIs) and can only be determined with urine culture, ideally 5 
to 7 days after therapy is terminated (Barsanti & Finco 1979, Ball 
et al. 2008, Olin & Bartges 2015).
Urine samples for microbiological examination should ideally 
be collected from all patients suspected of bacterial UTI before 
the initiation of antibiotic treatment to confirm the diagnosis and 
determine the aetiology of the infection. Empirical treatment, 
while laboratory results are pending, is usually recommended to 
relieve patient discomfort (Weese et al. 2011). An aetiological 
diagnosis may not be pursued due to financial constraints of the 
pet owner and/or a good initial response to empirical antibiotics. 
Consequently, continuation with the selected treatment occurs 
without any testing. Current knowledge on the local suscepti-
bility patterns of the most common uropathogens is therefore 
necessary to ensure adequate empiric antibiotic coverage. Antibi-
otic choices should also take into account the therapeutic levels 
reached in urine; therefore antibiotics with high renal excretion 
rates are preferred (Kramer et al. 2012). Inadequate empirical 
choices can lead to poor patient outcomes and contribute to the 
selection of resistance.
The emergence of multidrug-resistant (MDR) UTIs, which 
has already been reported (Cohn et al. 2003, Penna et al. 2010), 
can seriously complicate the treatment of these infections by lim-
iting the effective drugs available. There are also public health 
concerns associated with the potential zoonotic transmission of 
some of these resistant organisms, which is facilitated by the close 
proximity between humans and their household pets (Starcic 
et al. 2002, Guardabassi et al. 2004, Weese 2008, Rampacci 
et al. 2018).
The objectives of the present study were to provide evidence 
on the aetiology and antibiotic resistance of bacterial uropatho-
gens in dogs and cats in the UK using retrospective data from 
referrals to a diagnostic laboratory.
MATERIALS AND METHODS
Data collection
Data from urine samples from dogs and cats with significant 
bacteraemia submitted to NationWide Laboratories (NWL; 
Lancashire, UK) for microbiological examination between 
November 2011 and November 2012 were retrieved from elec-
tronic records. The geographic distribution of the veterinary 
practices from which the samples were originated is shown in 
Fig 1. Information on the method of urine collection was not 
provided by the requesting veterinarian. Urine samples of an 
animal were only submitted once (non-repetitive samples). The 
collected data included age and gender of the patients and the 
results from uroculture and antibiotic susceptibility testing. A 
cut-off of ≥105 colony-forming units (CFU)/mL and growth of 
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up to two possible uropathogens was used to define clinically 
significant bacteriuria (Sørensen et al. 2016). Only samples that 
matched these criteria were included in the analysis and if more 
than two isolates were cultured this was considered contami-
nated. Information on the clinical status of the patient (signs of a 
UTI or subclinical infections) was not provided but samples were 
submitted for clinical purposes, e.g. clinical suspicion of a UTI or 
screening susceptible patients.
Laboratory methods
Semi-quantitative bacterial cultures of undiluted urine samples 
were performed by the calibrated loop method. A 10-μL loop 
was used to inoculate the urine onto 5% blood agar and Mac-
Conkey agar. The plates were placed at 37°C and checked for 
growth after 18 to 24 hours of incubation. Bacteria were identi-
fied by Gram stain and standard biochemical procedures. Anti-
microbial susceptibility testing was done by the Kirby-Bauer 
method according to the recommendations of the Clinical and 
Laboratory Standards Institute (CLSI 2008). Quality control 
strains (Staphylococcus aureus ATCC 25923, Escherichia coli 
ATCC 25922, Pseudomonas aeruginosa ATCC 27853) were pre-
pared and tested by exactly the same methods as employed for 
the test isolates. NWL where the microbiological testing was 
carried out held an ISO17025 accreditation for clinical micro-
biology testing of urine. The antibiotics tested were penicillin, 
ampicillin, amoxicillin-clavulanic acid, cephalothin, cefovecin, 
tetracycline, enrofloxacin, marbofloxacin, erythromycin and tri-
methoprim-sulfamethoxazole. Clinical breakpoints defined by 
CLSI (CLSI 2008) were applied and noted differences in break-
point data between CLSI (2008) and CLSI VET01S (2020) are 
included in Table 1.
Data analysis
Data records were exported in a single batch from the Labora-
tory Information system by NWL (Winpath, Clinisys) using 
the application’s query function. All records with a species code 
“canine” or “feline” and a test request code “urine culture” were 
included in a comma-separated format that was then imported 
into Microsoft Excel. Results were further analysed by a single 
operator. Results were expressed as percentages. The frequency 
of different bacterial species in urine specimens was calculated 
by dividing the number of isolates from a certain species by the 
total number of isolates of this species from the canine and feline 
samples. For each antibiotic, the percentage of resistance was cal-
culated by dividing the number of resistant isolates by the total 
number of isolates reported.
Table 1. Clinical breakpoints used were from CLSI (2008) except for cefovecin which were obtained from Zoetis’ 
breakpoint data. The right part of the table indicates the breakpoint changes for amoxicillin-clavulanic acid and 
tetracycline (CLSI 2020)
Antimicrobial agent Disk content CLSI (2008) CLSI VET01S (2020)
Zone diameter (mm) Zone diameter (mm)
S I R Bacterial species Disk content S I R
Penicillin (human)
Staphylococci 10 units ≥29 – ≤28
Enterococci 10 units ≥15 – ≤14
Ampicillin (human)
Enterobacteriales 10 μg ≥17 14 to 16 ≤13
Staphylococci 10 μg ≥29 – ≤28
Enterococci 10 μg ≥17 – ≤16
Amoxicillin-clavulanic acid (human)
Staphylococci 20/10 μg ≥20 – ≤19
Other organisms 20/10 μg ≥18 14 to 17 ≤13 E. coli (dogs and 
cats)
20/10 μg ≥18 – –




30 μg ≥24 ≤20
Staphylococci 30 μg ≥24 ≤20
Tetracycline (human)
Organisms other than streptococci 
(includes Enterobacteriales and 
Staphylococcus spp.)
30 μg ≥19 15 to 18 ≤14 Enterobacteriales 
(human)
30 μg ≥15 12 to 14 ≤11
Enrofloxacin
Dogs 5 μg ≥23 17 to 22 ≤16
Marbofloxacin
Dogs 5 μg ≥20 15 to 19 ≤14
Erythromycin (human)
Enterococcus spp. 15 μg ≥23 14 to 22 ≤13
Staphylococcus spp. 15 μg ≥23 14 to 22 ≤13
Trimethoprim-sulfamethoxazole 
(human)
Staphylococcus spp. 1.25/23.75 μg ≥16 11 to 15 ≤10
Enterobacteriales 1.25/23.75 μg ≥16 11 to 15 ≤10
S Sensitive, I Intermediate, R Resistant
Breakpoints for dogs have been extrapolated to cats
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RESULTS
Microbiological results were available for a total of 5170 non-
repetitive urine samples, 3460 from dogs and 1710 from cats. 
Bacterial growth was recorded for 1547 of these samples but 
only 808 [637 (18.4%) from dogs and 171 (10.0%) from 
cats] matched our inclusion criteria. Significant bacteriuria was 
detected in 18.4% of samples from dogs and 10.0% from cats, 
most of which (>90%) yielded a single organism.
Age and sex of the patients
Information about the age and gender of the patient was available 
for 152 of 171 samples from cats and 586 of 637 samples from dogs. 
Age and gender distributions are shown in Table 2. More than half 
of the samples from dogs and cats (808) belonged to female dogs 
(52.7%; n=426); for cats this figure amounted to 10.4% (n=84).
Bacterial isolates
Most urine specimens from both cats (94.2%) and dogs (94.3%) 
yielded the pure growth of a single organism. Two different iso-
lates were present in the remaining samples (approximately 6% 
for cat and dog samples each).
Gram-negative species predominated, particularly those 
belonging to the Enterobacteriales which represented 57.3% and 
76.6% of the isolates obtained from feline and canine samples, 
respectively. E. coli was the most frequently isolated bacterium; 
54.7% in cats and 55.6% in dogs (Table 3), followed by Proteus 
mirabilis in dog samples and Enterococcus spp. in cat samples. 
Additionally, almost 10% of isolates from cats yielded coagulase-
negative staphylococci. SIG was the most frequently isolated 
coagulase-positive Staphylococcus with 4.4% and 7% of isolates 
from cat and dog samples, respectively.
The most common combinations in canine samples that 
yielded mixed bacterial growth were E. coli/β-haemolytic strepto-
cocci (n=8), E. coli/P. mirabilis (n=7), P. mirabilis/Enterococcus spp. 
(n=5), E. coli/Enterococcus spp. (n=4) and Staphylococcus interme-
dius Group/β-haemolytic streptococci (n=4). E. coli/Enterococcus 
spp. (n=6) was the most common combination in feline samples.
Antibiotic susceptibility
The great majority of isolates obtained from cat and dog samples 
(96.7% and 96.1%, respectively) were susceptible to at least one 
of the oral antibiotics commonly prescribed to UTI patients 
(ampicillin, amoxicillin-clavulanic acid, cephalothin, tetracycline 
and trimethoprim-sulfamethoxazole). Out of these, trimethoprim-
sulfamethoxazole and amoxicillin-clavulanic acid were the drugs 
with the lowest percentage of resistance (Table 4). Resistance 
above 20% was detected to cephalothin and cefovecin for E. coli, 
with the highest resistance against cephalothin (64.4%). Overall, 
36.9% of E. coli isolates from canine samples and 39.4% from 
feline samples were resistant to ampicillin and almost 20% were 
resistant to amoxicillin-clavulanic acid in cats and dogs. Resistance 
to erythromycin and tetracycline was detected in approximately 
90% and 50% of enterococcal isolates respectively, and 10% of 
the canine enterococci were resistant to ampicillin and amoxicil-
lin-clavulanic acid, whereas no resistance was observed among the 
feline enterococci. Fluoroquinolones showed good in vitro activ-
ity against the isolates included in our study (resistance 0–7.3% 
for enrofloxacin and marbofloxacin) excluding coagulase-negative 
staphylococci with 0% to 17.6% resistance. Staphylococci isolates 
displayed high resistance to penicillin and ampicillin, but resis-
tance to trimethoprim-sulfamethoxazole and cefovecin was much 
lower (Table 4).
DISCUSSION
Inadequate empirical choices or antibiotic treatment of nonbac-
terial conditions such as feline idiopathic/interstitial cystitis can 
lead to poor patient outcomes and contribute to the selection of 
resistance, particularly given the long courses of antibiotic treat-
ment usually preferred in companion animal medicine compared 
to human treatment regimes (Rampacci et al. 2018). Previous 
Table 3. Bacterial species isolated from urine samples 
with significant bacteriuria
Bacterial species Percentage of isolates (%)
Cats (n=171) Dogs (n=637)
Gram-negative 59.7 (102) 79.0 (503)
Enterobacteriales 57.3 (98) 76.6 (488)
Escherichia coli 54.7 (94) 55.6 (354)
Proteus mirabilis 2.2 (4) 22.7 (145)
Gram-positive 40.3 (69) 21 (134)
Enterococcus spp. 23.2 (40) 6.3 (40)
β-haemolytic streptococci 1.7 (3) 5.6 (36)
Coagulase-negative staphylococci 9.9 (17) 2.3 (15)
Staphylococcus intermedius group 4.4 (8) 7.0 (45)
Table 2. Age and sex distribution of canine and feline patients with significant bacteriuria
Number of samples (%)
Total dogsCats Dogs
Males Females Total cats Males Females
Age groups (years)
<1 2 (2.9) 0 (0) 2 (1.3) 11 (6.9) 49 (11.5) 60 (10.2)
1–4 14 (20.6) 9 (10.7) 23 (15.1) 27 (16.9) 73 (17.1) 100 (17.1)
5–7 8 (11.8) 9 (10.7) 17 (11.2) 26 (16.3) 86 (20.2) 112 (19.1)
8–10 13 (19.1) 16 (19.0) 29 (19.1) 47 (29.4) 116 (27.2) 163 (27.8)
≥11 31 (45.6) 50 (59.5) 81 (53.3) 49 (30.6) 102 (23.9) 151 (25.8)
Age range 2 months to 
20 years
1–31 years 3 months to 
16 years
2 months to 
17 years
Percentages in brackets were calculated by dividing the number of samples in each age group by the total number of samples from each gender and multiplying by 100
Urinary tract infections in cats and dogs
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veterinary guidelines (Weese et al. 2011) advised 7- to 14-day 
antimicrobial courses but more recent studies indicate that the 
use of short duration therapy, as used in humans, may be as 
effective although different dosing regimes and antimicrobials 
still need to be more specifically evaluated (Weese et al. 2019). 
Empirical antibiotic choices should take into consideration the 
local susceptibilities of the uropathogens most likely to be impli-
cated. It is, therefore, important to monitor changes in the aetiol-
ogy and antibiotic resistance of UTIs in cats and dogs.
We detected bacteriuria in 30% (1547/5170) of the urinary 
samples submitted to the laboratories which was similar to previ-
ous reports (Guardabassi et al. 2015, KuKanich & Lubbers 2015). 
A low prevalence of samples containing two or more isolates was 
detected as most samples yielded the pure growth of a single organ-
ism; this is in agreement with previous studies (Ling et al. 2001, 
Ball et al. 2008, Lund et al. 2015, Rampacci et al. 2018). The num-
ber of urine samples from canine patients submitted for microbio-
logical examination during the span of our study was double that 
of feline patients which may reflect that UTIs are more common 
in dogs (Buffington et al. 1997). Another possibility is that sam-
pling is performed more readily in dogs than cats or the higher 
number of pet dogs than cats in the UK (26% and 31% of the 
UK households own cats and dogs) could have contributed to this 
difference (Murray et al. 2010). Positive samples were more com-
monly from older female dogs, which are known to be at greater 
risk of developing UTI (Bush 1976, Kivisto et al. 1977, Thomsen 
et al. 1986, Ling et al. 2001). The mean age of patients with sig-
nificant bacteriuria, regardless of sex, was approximately 7 years 
in dogs and 11 years in cats, in agreement with previous studies 
(Lekcharoensuk et al. 2001, Ling et al. 2001, Cohn et al. 2003).
Amoxicillin, amoxicillin-clavulanic acid, cephalexin, doxy-
cycline and trimethoprim-sulfamethoxazole are defined as oral 
antibiotics commonly used in the treatment of uncomplicated 
UTIs (sporadic UTIs in an otherwise healthy animal with a nor-
mal urinary tract anatomy and function) (Norris et al. 2000, De 
Briyne et al. 2014, BSAVA 2018). Fluoroquinolones and second 
or third-generation cephalosporins are considered second-line 
antibiotics and are to be used only where there is culture evidence 
that first-line drugs will not be effective (Norris et al. 2000, Olin 
& Bartges 2015).
E. coli has been recognised as the most common bacterial cause 
of UTIs in dogs and cats as noted in our study (Ling et al. 2001, 
Penna et al. 2010, Hall et al. 2013, Dorsch et al. 2015, Moyaert 
et al. 2017). In agreement with similar studies, resistance above 
20% was detected to cephalosporins by E. coli in our study, with 
the highest (64.4%) being against a first-generation cephalo-
sporin (cephalothin) and 31.2% resistant to a third-generation 
cephalosporin (cefovecin) in canine E. coli (Weese et al. 2011, 
Rampacci et al. 2018). This indicates the need to continue moni-
toring resistance against cephalosporins, especially those of the 
third generation (e.g. cefovecin) and reserving them solely for 
difficult cases where culture and susceptibility indicate first-line 
drugs are not susceptible in order to preserve their efficacy for 
human and veterinary medicine.
Overall, we observed a predominance of Gram-negative spe-
cies over Gram-positive species, even though this difference 
was less marked in samples from feline patients due to a higher 
prevalence of Enterococcus spp. and coagulase-negative staphylo-
cocci. Similarly to previous reports (Litster et al. 2007), Entero-
coccus spp. was the second most frequent urinary pathogen in 
cat samples. In humans, this opportunistic organism causes dif-
ficult-to-treat infections that usually affect geriatric patients with 
concurrent diseases and is often associated with implanted medi-
cal devices. Furthermore, intrinsic resistance of certain Entero-
coccus spp. such as Enterococcus faecalis to streptogramins and 
Enterococcus faecium to β-lactam antibiotics have been previous 
reported (Fontana et al. 1996, Jackson et al. 2009). In our study, 
60% of enterococcal isolates were from samples from patients 
above the age of 9 years. We detected resistance to erythromycin 
and tetracycline in approximately 90% and 50% of enterococcal 
isolates respectively from dogs and cats and although licensed, 
these antimicrobials are not recommended for UTIs in dogs 
and cats (BSAVA 2018, Weese et al. 2019). In addition, in vitro 
resistance does not necessarily correlate with bacteriological cure 
as most in vitro susceptibility breakpoints are based on achiev-
able serum concentrations, which can be significantly lower than 
Table 4. Antibiotic resistance profiles of bacteria isolated from urine samples with significant bacteriuria
Bacterial species Animal 
species
Antibiotic (% of resistant isolates)
P* AMP* AMC* CEF* CVN† TET‡ ENR† MAR† E‡ SXT*
Escherichia coli Dogs 36.9 16.8 64.4 31.2 11.1 7.3 6.5 12.6
Cats 39.4 19.2 58.8 26.8 19.2 7.1 7.1 8.2
Proteus mirabilis Dogs 11.7 4.8 6.9 2.8 4.1 0.7 19.4
Cats§ – – – – – – –
Enterococcus spp. Dogs 10 10 10 47.5 90




Dogs 80 80 0 24.4 4.4 0 11.1
Cats§ 50 50 0 12.5 0 0 0
Coagulase-negative 
staphylococci
Dogs 60 60 20 40 13.3 13.3 6.7
Cats 17.6 17.6 11.8 5.9 17.6 0 11.8
P Penicillin, AMP Ampicillin, AMC Amoxicillin-clavulanic acid, CEF Cephalothin, CVN Cefovecin, TET Tetracycline, ENR Enrofloxacin, MAR Marbofloxacin, E Erythromycin, SXT Trimethoprim-
sulfamethoxazole
Inferred resistance for certain antibiotics: Amoxicillin inferred from ampicillin, first-generation cephalosporins (e.g. cephalexin) inferred from cephalothin, doxycycline inferred from tetracycline
*Antibiotics commonly used in the treatment of uncomplicated UTIs
†Antibiotics used second line for the treatment of UTIs, only where there is culture and sensitivity evidence that first-line drugs will not be effective
‡Antibiotics not recommended for the treatment of UTIs
§n < 10
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those attained in urine for antibiotics with renal excretion (such 
as amoxicillin) and in animals that can concentrate urine.
In our study, almost 10% of samples from cats with signifi-
cant bacteriuria yielded the pure growth of coagulase-negative 
staphylococci. The role of these organisms in canine and feline 
UTIs is not wholly understood but our findings give support to 
the view that they are relevant aetiologic agents of these infec-
tions. A previous study of urine samples from dogs with UTI 
implicated Staphylococcus epidermidis, Staphylococcus simulans, 
Staphylococcus schleiferi and Staphylococcus saprophyticus (Penna 
et al. 2010) and a more recent study has elucidated the species 
of coagulase-negative staphylococci recovered from the urinary 
tracts of both cats and dogs (Moyaert et al. 2017). SIG includ-
ing the major representative Staphylococcus pseudintermedius are 
the leading cause of staphylococcal infections in dogs, including 
UTIs (Lilenbaum et al. 2000, Ganière et al. 2005). It was the 
most frequently isolated coagulase-positive staphylococci in our 
study and represented 4.4% and 7.0% of isolates from cat and 
dog samples, respectively.
Amoxicillin is recommended as a first-line choice for the treat-
ment of uncomplicated UTI (Weese et al. 2019). In our study, 
ampicillin was used to predict susceptibilities to amoxicillin, the 
latter is preferred for treatment as it has a better oral bioavailabil-
ity. A considerable number of isolates, particularly E. coli, S. pseud-
intermedius and coagulase-negative staphylococci, obtained from 
samples with significant bacteriuria were refractory to ampicil-
lin. Overall, 36.9% of E. coli isolates from canine samples and 
39.4% from feline samples were resistant to ampicillin. It is usu-
ally recommended that an antibiotic should not be used in the 
empirical treatment of UTIs if resistance rates exceed 10% to 20% 
among the most common uropathogens due to an increased risk 
of poor patient outcomes (Steen 2011). Our results suggest that 
ampicillin might not be a good antibiotic choice for the empiri-
cal treatment of canine and feline UTIs in the UK; however, they 
should be interpreted with caution. Studies can overestimate the 
prevalence of antibiotic resistance because they are often biased 
towards more serious cases (e.g. recurrent UTIs, patients that do 
not respond to empirical therapy) which are also more likely to 
be antibiotic resistant (Steen 2011). A lower prevalence of E. coli 
resistance to ampicillin (approximately 20%) was observed in a 
recent pan-European study of UTI isolates from cats and dogs not 
recently exposed to antibiotics (Moyaert et al. 2017).
In our study, clavulanate potentiated amoxicillin was active 
in vitro against approximately 50% of isolates that were resistant 
to ampicillin alone. We detected 16.8% to 19.2% prevalence of 
amoxicillin-clavulanic acid resistance among E. coli isolates, in 
agreement with previous reports (Marques et al. 2016). Our find-
ings point to the need to monitor the levels of amoxicillin/amox-
icillin-clavulanic acid resistance in UTIs of cats and dogs. More 
recent studies indicate that there is limited evidence for the need 
to use clavulanic acid as an addition to amoxicillin and its use may 
not be essential, even with beta-lactamase-producing bacteria, due 
to the high concentrations of amoxicillin reached in urine (Weese 
et al. 2019). Trimethoprim-sulfonamides are another advocated 
first-line option for the empirical treatment of uncomplicated 
UTIs in dogs and cats (Weese et al. 2011, Rampacci et al. 2018) 
and, according to our results, might be superior to amoxicillin 
due to lower resistance rates. Although this should be interpreted 
with caution due to our low cat sample size (171), this antibi-
otic has had controversial activity against this bacterial species in 
other studies with relatively greater associated side effects (Weese 
et al. 2019).
It is generally recommended that, in order to preserve their 
effectiveness, the use of broad-spectrum antibiotics should be 
reserved for cases that do not respond to narrow-spectrum anti-
biotics and guided by documented in vitro susceptibility of the 
offending organisms (Weese et al. 2011). Enrofloxacin and marbo-
floxacin were the antibiotics routinely tested that showed greater 
in vitro activity against the most common uropathogens (over-
all susceptibility above 90%) despite previous reports showing 
an increase in resistance to fluoroquinolones (Cooke et al. 2002, 
Cohn et al. 2003) and reports after the conduction of this study 
showing similar results (Maluping et al. 2014, Marques et al. 2016, 
Rampacci et al. 2018). Research has been pointing to the efficacy 
of a high-dose, short-course regimen of enrofloxacin in attaining 
bacteriological cure in uncomplicated UTI cases in dogs and simi-
lar results have been obtained with trimethoprim-sulfamethoxa-
zole (Westropp et al. 2012, Olin & Bartges 2015). Short courses 
of antibiotics have the advantages of increasing owner compliance 
and reducing the costs and toxicity associated with treatment. 
Although fluoroquinolones can be effective in the treatment of 
UTIs, their use in animals is discouraged due to public health and 
antimicrobial resistance concerns (Weese et al. 2019).
In this study, we used the methods that were the standard of 
practice at the time of the study, including identification methods 
and CLSI breakpoints due to their specificity for bacteria isolated 
from animals (CLSI 2008). Since then new standards have been 
developed (CLSI VET01S 2020) which raise laboratory testing 
quality and should be used for previous and current studies in 
order to obtain the correct susceptibility data in all studies, but 
this process is far from complete. For example, there are far more 
breakpoints for pathogens from dogs than those from cats and 
we lack breakpoints on certain important bacteria which high-
lights the need to continuously update these standards (Moyaert 
et al. 2017). In addition, the fact that information on the method 
of urine collection was often not provided by veterinary surgeons 
may have further impacted the results as different cut-off for sig-
nificance are used depending on the collection method. The cut-
off for this study was ≥105 CFU/mL but significant pathological 
infections in cystocentesis samples may not have been included 
as they can be detected at <105 and >103 CFU/mL (Sørensen 
et al. 2016).
E. coli continues to be the most common cause of UTIs in 
dogs and cats with the detection of notable resistance to cephalo-
sporins in our study. Enterococcus spp. were frequently detected in 
cat samples with high resistance to erythromycin and tetracycline 
and low resistance to ampicillin and amoxicillin-clavulanic acid. 
Our findings support the view that Staphylococcus spp. are relevant 
aetiologic agents of bacterial UTIs indicating the need for further 
studies on the species of coagulase-negative staphylococci associ-
ated with these infections. Considerable resistance to ampicillin 
and amoxicillin-clavulanic acid from several isolates was identified 
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which is in contrast to that of trimethoprim-sulfamethoxazole 
which was low. Enrofloxacin and marbofloxacin showed the best 
in vitro activity against the isolates tested. Our findings provide 
evidence of the emergence of resistance to antibiotics commonly 
used in the treatment of UTIs in dogs and cats among the uro-
pathogens most likely to be responsible for these infections in the 
UK. Changes in the aetiology and antibiotic resistance of UTIs 
should be continuously monitored to evaluate the need to intro-
duce changes in the recommendations (e.g. ISCAID guidelines, 
Weese et al. 2019) about empiric therapy when antimicrobial sus-
ceptibility testing is not possible or pending.
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